Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.040
-0.020 (-1.89%)
At close: Apr 28, 2026, 4:00 PM EDT
1.097
+0.057 (5.46%)
After-hours: Apr 28, 2026, 7:38 PM EDT
Lucid Diagnostics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Lucid Diagnostics stock have an average target of 4.13, with a low estimate of 2.00 and a high estimate of 9.00. The average target predicts an increase of 297.12% from the current stock price of 1.04.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Lucid Diagnostics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $8.25 → $9 | Strong Buy | Maintains | $8.25 → $9 | +765.38% | Apr 9, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $2.5 | Strong Buy | Reiterates | $2.5 | +140.38% | Mar 30, 2026 |
| Needham | Needham | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +188.46% | Mar 26, 2026 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $8 → $8.25 | Strong Buy | Maintains | $8 → $8.25 | +693.27% | Dec 10, 2025 |
| Needham | Needham | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +188.46% | Nov 13, 2025 |
Financial Forecast
Revenue This Year
10.15M
from 4.71M
Increased by 115.58%
Revenue Next Year
23.39M
from 10.15M
Increased by 130.54%
EPS This Year
-0.28
from -0.69
EPS Next Year
-0.21
from -0.28
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 11.9M | 42.0M | |||
| Avg | 10.1M | 23.4M | |||
| Low | 7.8M | 14.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 152.1% | 314.0% | |||
| Avg | 115.6% | 130.5% | |||
| Low | 66.6% | 42.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.26 | -0.20 | |||
| Avg | -0.28 | -0.21 | |||
| Low | -0.28 | -0.22 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.